Prostate Cancer Connect
  • Saved



Conclusions: Results of this cohort study suggest that the option of virtual attendance at professional conferences may be associated with reduced carbon emissions. Numerous alternatives to in-person conference exist including (1) hosting hybrid conferences with both in-person and online attendance options, (2) alternating annual meetings...

  • Saved
Now is it time to implement spacers in cervical cancer brachytherapy?

Now is it time to implement spacers in cervical cancer brachytherapy?

Source : https://academic.oup.com/jrr/advance-article/doi/10.1093/jrr/rrac031/6611801?login=false

Since the introduction of image-guided adaptive brachytherapy (IGABT) for uterine cervical cancer in 2005 [ 1], the Gynecological (GYN) The Groupe Europen de Curiethrapie and the European Society for Radiotherapy...


Conclusion: The authors believe that using a spacer in cervical cancer brachytherapy and brachytherapy for other gynecologic malignancies will reduce late radiation-related toxicity and improve patients’ quality of life; therefore, its rapid implementation is required.

  • Saved
Prostate MRI in Stereotactic Body Radiation Treatment Planning and Delivery for Localized Prostate Cancer

Prostate MRI in Stereotactic Body Radiation Treatment Planning and Delivery for Localized Prostate Cancer

Source : https://pubs.rsna.org/doi/10.1148/rg.210114

Prostate MRI is increasingly being used to make diagnoses and guide management for patients receiving definitive radiation treatment for prostate cancer. Radiologists should be familiar with the potential uses of...


Conclusion/Relevance: Specific topics discussed include the use of prostate MRI for identification of and dose reduction to the membranous and prostatic urethra, which can decrease the risk of acute and late toxicities. MRI is also useful for identification and appropriate dose coverage of the prostate apex and areas of extraprostatic extension...

  • Saved
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601

Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601

Source : https://ascopubs.org/doi/10.1200/JCO.21.02741

PURPOSE Metastasis-free survival (MFS), but not event-free survival, is a validated surrogate end point for overall survival (OS) in men treated for localized prostate cancer. It remains unknown if this...


Conclusion: MFS is also a strong surrogate for OS in men receiving salvage radiation therapy for recurrence after prostatectomy. Caution should be used when inferring survival benefit from effects on BF in biochemically recurrent prostate cancer. Lack of comorbidity data did not allow us to assess whether BF in men with no/minimal comorbidity...

  • Saved
Continuous liquid interface production of 3D printed drug-loaded spacers to improve prostate cancer brachytherapy treatment

Continuous liquid interface production of 3D printed drug-loaded spacers to improve prostate cancer brachytherapy treatment

Source : https://www.sciencedirect.com/science/article/abs/pii/S1742706122003610?via=ihub

Available online 17 June 2022 Brachytherapy, which is the placement of radioactive seeds directly into tissue such as the prostate, is an important curative treatment for prostate cancer. By delivering...


Conclusion: We found that drug-loaded spacers led to higher therapeutic efficacy for brachytherapy, and there was no discernable systemic toxicity from the drug-loaded spacers.